HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effectiveness of a novel semi-closed barrier device with a personalized exhaust in cough aerosol simulation according to particle counts and visualization of particles.

Abstract
Oxygen therapy is an essential treatment for patients with coronavirus disease 2019, although there is a risk of aerosolization of additional viral droplets occurring during this treatment that poses a danger to healthcare professionals. High-flow oxygen through nasal cannula (HFNC) is a vital treatment bridging low-flow oxygen therapy with tracheal intubation. Although many barrier devices (including devices without negative pressure in the barrier) have been reported in the literature, few barrier devices are suitable for HFNC and aerosol infection control procedures during HFNC have not yet been established. Hence, we built a single cough simulator model to examine the effectiveness of three protective measures (a semi-closed barrier device, a personalized exhaust, and surgical masks) administered in isolation as well as in combination using particle counter measurements and laser sheet visualization. We found that the addition of a personalized exhaust to a semi-closed barrier device reduced aerosol leakage during HFNC without negative pressure. This novel combination may thus reduce aerosol exposure during oxygen therapy, enhance the protection of healthcare workers, and likely reduce nosocomial infection risk.
AuthorsRyohei Matsui, Hiroshi Sasano, Takafumi Azami, Hisako Yano, Hiromi Yoshikawa, Yota Yamagishi, Takahiro Goshima, Yuka Miyazaki, Kazunori Imai, Marechika Tsubouchi, Yoichi Matsuo, Shuji Takiguchi, Tomonori Hattori
JournalIndoor air (Indoor Air) Vol. 32 Issue 2 Pg. e12988 (02 2022) ISSN: 1600-0668 [Electronic] England
PMID35225390 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Topics
  • Air Microbiology
  • Air Pollution, Indoor
  • COVID-19
  • Cough
  • Humans
  • Respiratory Aerosols and Droplets
  • SARS-CoV-2

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: